Hellodolly1

Inovio Pharmaceuticals - Short term not only COVID

Long
NASDAQ:INO   Inovio Pharmaceuticals, Inc.
Next 45 days packed with potential catalysts -
Friday ASCO poster with REGN regarding 2nd Cohort 85% 12 Month OS, Glioblastoma GBM
Results from COVID animal challenge data on ferrets and monkeys, (mice and guinea pigs published last week),
CEPI funding announcement, WHO, GATTES?
COVID PHII announcements in Korea and China,
FDA Approval PHII U.S.,
Inclusion in Warp Speed announcement,
Prostate Trials - Parker Institute

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.